Prevalence and impact of chronic hepatitis C virus infection on the clinical manifestations and disease activity among patients suffering from systemic lupus erythematosus

Egyptian Rheumatologist - Tập 35 - Trang 9-14 - 2013
Ayman El Garf1, Noha Shaheen2, Wafaa Gaber1, Nesreen Sobhy1
1Department of Rheumatology and Rehabilitation, Faculty of medicine, Cairo University, Cairo, Egypt
2Department of Clinical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt

Tài liệu tham khảo

Choo, 1989, Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome, Science, 244, 359, 10.1126/science.2523562 Lauer, 2001, Hepatitis C virus infection, New Eng J Med, 345, 41, 10.1056/NEJM200107053450107 Strickland, 2002, Role of hepatitis C infection in chronic liver disease in Egypt, Am J Trop Med Hyg, 67, 436, 10.4269/ajtmh.2002.67.436 Strickland, 2006, Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors, Hepatology, 43, 915, 10.1002/hep.21173 Armstrong, 2006, The prevalence of hepatitis C virus infection in the United States, 1999 through 2002, Ann Intern Med, 144, 705, 10.7326/0003-4819-144-10-200605160-00004 El Garf, 2012, Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward, Rheumatol Int, 32, 2691, 10.1007/s00296-011-2014-8 Ramos-Casal, 2000, Hepatitis C virus infection mimicking systemic lupus erythematosus: study on hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus, Arthritis Rheum, 43, 2801, 10.1002/1529-0131(200012)43:12<2801::AID-ANR21>3.0.CO;2-V Feng, 2006, Hepatitis C virus infection combined with systemic lupus erythematosus, Zhong Nan Da Xue Xue Bao Yi Xue Ban, 31, 891 Costa, 2002, Prevalence of hepatitis C in patients with systemic lupus erythematosus in the Hospital of Federal University of Rio de Janeiro (HUCCF), Rev Assoc Med Bras, 48, 42, 10.1590/S0104-42302002000100031 Mercado, 2005, Prevalence of antibodies against hepatitis C and B viruses in patients with systemic lupus erythematosus, Rev Gastroenterol Mex, 70, 399 Abu-Shakra, 1997, Hepatitis B and C viruses serology in patients with SLE, Lupus, 6, 543, 10.1177/096120339700600612 Himoto, 2008, Autoantibodies in hepatitis C virus-related chronic liver disease, Hepat Mon, 8, 295 Fournie, 2001, Induction of autoimmunity through bystander effects: lessons from immunological disorders induced by heavy metals, J Autoimmun, 16, 319, 10.1006/jaut.2000.0482 Toubi, 2006, Elevated serum B-lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity, J Autoimmun, 27, 134, 10.1016/j.jaut.2006.07.005 Kessel, 2007, Chronic HCV-related autoimmunity: a consequence of viral persistence and lymphotropism, Curr Med Chem, 14, 547, 10.2174/092986707780059652 Hochberg, 1997, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 40, 1725, 10.1002/art.1780400928 Bombardier, 1992, Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE, Arthritis Rheum, 35, 630, 10.1002/art.1780350606 Gharavi, 1987, Anticardiolipin antibodies: isotype distribution and phospholipid specificity, Ann Rheum Dis, 46, 1, 10.1136/ard.46.1.1 Cervera, 1990, Isotype distribution of anticardiolipin antibodies in systemic lupus: prospective analysis of a series of 100 patients, Ann Rheum Dis, 49, 109, 10.1136/ard.49.2.109 Alter, 1994, The epidemiology of viral hepatitis in the United States, Gastroenterol Clin North Am, 23, 437, 10.1016/S0889-8553(21)00146-1 Yen, 2003, The epidemiology of hepatitis C virus infection, J Clin Gastroenterol, 36, 47, 10.1097/00004836-200301000-00015 Alter, 1999, The prevalence of hepatitis C virus infection in the United States, 1988 through 1994, N Engl J Med, 341, 556, 10.1056/NEJM199908193410802 Glynn, 2000, Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991–1996. Retrovirus Epidemiology Donor Study (REDS), JAMA, 284, 229, 10.1001/jama.284.2.229 Puchner, 2009, Extrahepatic manifestations of chronic hepatitis C virus infection, Z Gastroenterol, 47, 446, 10.1055/s-0028-1109296 Lormeau, 2006, Rheumatologic manifestations of chronic hepatitis C infection, Joint Bone Spine, 73, 633, 10.1016/j.jbspin.2006.05.005 Cacoub, 2000, Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC, Medicine (Baltimore), 79, 47, 10.1097/00005792-200001000-00005 Lee, 1998, Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection, Ann Rheum Dis, 57, 728, 10.1136/ard.57.12.728 Buskila, 1998, Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients, Semin Arthritis Rheum, 28, 107, 10.1016/S0049-0172(98)80043-7 Barbosa, 2005, Hepatitis C virus seroprevalence and genotypes in patients with diffuse connective tissue diseases and spondyloarthropathies, Braz J Med Biol Res, 38, 801, 10.1590/S0100-879X2005000500020 Mowla, 2008, Prevalence of hepatitis C virus infection in patients with systemic lupus erythematosus: a case-control study, Hepat Mon, 8, 41 Riccieri, 2005, Nailfold capillaroscopy changes in systemic lupus erythematosus. Correlation with disease activity and autoantibody profile, Lupus, 14, 521, 10.1191/0961203305lu2151oa Moez, 2008, Clinical and immunological manifestations of systemic lupus erythematosus: a study on 146 south Tunisian patients, Saudi J Kidney Dis Transpl, 19, 1001